IV Fluids Recalled Nationwide Over Particulate Contamination

Baxter International has issued volitional recalls for multiple intravenous solutions after inspectors found steel and fiberglass particulates in Viaflex bags distributed to hospitals and home-care patients nationwide. The recalls include two lots of 0.9% sodium chloride injections (lot Y495523 and Y495523A) packaged in 500 mL VIAFLEX containers, distributed July 31–Aug. 3 to numerous states, and a separate lot of 70% dextrose injection (lot Y4950663) distributed to Alabama, Georgia, and Tennessee between July 25–28. Health risks cited by the FDA and Baxter include vascular blockages, blood clots, pulmonary embolisms, organ damage, vein irritation, and potential allergic or inflammatory reactions, though no adverse events had been reported as of the notices. A related recall involves anticoagulant sodium citrate solution tied to broader quality concerns, with guidance that facilities should stop using affected products and return them per protocol. Baxter says customers should notify adverse events via the FDA MedWatch channel, and facilities should inform patients receiving recalled home-nutrition products about replacements. The recalls underscore ongoing concerns about particulate contamination across several IV solutions and highlight the need for providers to halt use and segregate and return affected lots promptly.